Isala
Zwolle, Netherlands
Treatment & access
- Treatments offeredEsketamine nasal spray (Spravato®)
- Access routeCovered by a national programme
- Cost & coverage (registry status)Reimbursed via Dutch basic health insurance (esketamine nasal spray for TRD)
- ReimbursementMember of Esketamine Neusspray Consortium (ENC-NL); esketamine covered per ENC-NL protocol How reimbursement works in Europe →
- Phone+31 88 624 50 00
- Websitehttps://www.isala.nl/aandoeningen-en-behandelingen/esketamine/
About this provider
Isala's psychiatry department in Zwolle runs an esketamine outpatient clinic for adults with difficult-to-treat (therapy-resistant) severe depression. Patients are referred by their own psychiatrist within the mental health system and must have tried at least two antidepressants without sufficient effect; esketamine is then used in addition to an antidepressant. The nasal spray is self-administered under supervision of a medical team, after checks such as blood pressure measurement; the strongest side effects have usually passed after about 1.5 hours. The treatment lasts half a year in total, starting with an induction phase of 4 to 8 weeks with two visits per week, followed by a maintenance phase of one visit per week and an optimisation phase up to six months. Isala participates in the national ENC-NL consortium coordinated by Radboudumc.
Services & programs
- Esketamine nasal spray treatment (Spravato) for adults with difficult-to-treat depression at the esketamine outpatient clinic, psychiatry department
- Participation in national ENC-NL research on longer-term outcomes of esketamine treatment
Common questions
How do I get referred?
Patients in the region are referred by their own psychiatrist within the mental health system. You must have tried at least two antidepressants before you can qualify; if esketamine is an option, it is given as an addition to an antidepressant.
What does a treatment visit look like?
You come to the department in the morning, where medical checks such as blood pressure measurement take place. After completing a questionnaire you lie down and administer the nasal spray yourself, under supervision of the medical team. Side effects such as high blood pressure, sleepiness and sometimes dissociation can occur; after about 1.5 hours the strongest effects have passed and you can go home.
How long does the treatment take?
Half a year in total. The induction phase lasts 4 to 8 weeks with two visits per week; if there is sufficient effect, a maintenance phase follows with one visit per week, and finally an optimisation phase until the six-month term is completed.
Is the treatment reimbursed?
Isala states the treatment is included in the depression guideline and is reimbursed; you can receive it if you have severe therapy-resistant depression and your insurer covers the costs.
2 more verified providers within 50 km
- Apeldoorn / Zutphen · 35 kmGelre Ziekenhuizen : Spravato®
- Ermelo · 39 kmGGZ Centraal : Spravato®
Verification
- License / registryLRZa (Landelijk Register Zorgaanbieders, CIBG) — Stichting Isala Klinieken, KvK 05062128; ENC-NL esketamine network member
- Official registryhttps://zoeken.zorgaanbiedersportaal.nl/zorgaanbieder/Stichting%20Isala%20Klinieken/05062128
- Provider websitehttps://www.isala.nl/aandoeningen-en-behandelingen/esketamine/
- Independent sourcehttps://enc-nl.nl/
- Last verified
Check your fit & enquire
Spravato® access in Netherlands follows published criteria. A short pre-screening comes first, then your compiled summary goes to Isala only with your explicit consent, and you can download it for yourself either way.
Why enquire via PsyAccess
- Pre-screening first. A 2-minute check in your browser shows which legal routes fit your situation, before you reach out to anyone.
- A structured enquiry. Your enquiry reaches the provider with a structured summary, so the clinic can reply quickly and to the point.
- Independent & free. Free for patients. We don't charge for enquiries, and no provider pays for placement.